Patents-Review.com
ClassID:

96785 ⎘

C07K14/075 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; DNA viruses Adenoviridae

Recent Application in this class:
#1
20250340599
2025-11-06

TARGETED PROTEIN DEGRADATION SYSTEM AND USE THEREOF

 #2
20250333454
2025-10-30

RECOMBINANT ADENOVIRUSES AND USES THEREOF

 #3
20250161383
2025-05-22

VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER

 #4
20250146013
2025-05-08

HIGH THROUGHPUT ASSAY FOR MEASURING ADENOVIRUS REPLICATION KINETICS

 #5
20250145670
2025-05-08

METHODS AND COMPOSITIONS FOR DUAL GLYCAN BINDING AAV VECTORS

 #6
20240327468
2024-10-03

METHODS AND COMPOSITIONS FOR DUAL GLYCAN BINDING AAV VECTORS

 #7
20240317814
2024-09-26

Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism

 #8
20240287142
2024-08-29

Recombinant adenoviruses and uses thereof

 #9
20240091378
2024-03-21

Compositions and methods of treating ocular diseases

 #10
20240059743
2024-02-22

AAV CAPSIDS AND VECTORS

 #11
20230416311
2023-12-28

Influenza vaccines

 #12
20230331786
2023-10-19

ADENOVIRUS COMPRISING AN ALBUMIN-BINDING MOIETY

 #13
20230313224
2023-10-05

INTEGRATION OF LARGE ADENOVIRUS PAYLOADS

 #14
20230304039
2023-09-28

NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS WITH ENHANCED HUMAN PANCREATIC TROPISM

 #15
20230302381
2023-09-28

METAL-AFFINITY EXTRACTION OF HOST CELL DNA

 #16
20230295243
2023-09-21

COMPOSITION AND METHOD FOR TREATING EYE DISEASES

 #17
20230265382
2023-08-24

PRODUCTION SYSTEM FOR HELPER-DEPENDENT ADENOVIRUS

 #18
20230257770
2023-08-17

Process for Making Adenoassociated Viral Vectors

 #19
20230220014
2023-07-13

ADENO-ASSOCIATED VIRUS WITH ENGINEERED CAPSID

 #20
20230183297
2023-06-15

METHODS OF TREATMENT AND RELATED COMPOSITIONS

 #21
20230086710
2023-03-23

AAV CAPSID VARIANTS

 #22
20230073187
2023-03-09

PROSTATE TARGETING ADENO-ASSOCIATED VIRUS SEROTYPE VECTORS

 #23
20230040878
2023-02-09

METHOD FOR PREPARING GENETICALLY-MODIFIED T CELLS WHICH EXPRESS CHIMERIC ANTIGEN RECEPTOR

 #24
20230002451
2023-01-05

VIRAL CAPSID POLYPEPTIDES

 #25
20230001014
2023-01-05

DETARGETED ADENOVIRUS VARIANTS AND RELATED METHODS

 #26
20220380438
2022-12-01

TREATMENT

 #27
20220380413
2022-12-01

Adeno-Associated Viral Vectors for Crossing the Human Blood Brain Barrier

 #28
20220347317
2022-11-03

AAVRH74 VECTORS FOR GENE THERAPY OF MUSCULAR DYSTROPHIES

 #29
20220257678
2022-08-18

Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency

 #30
20220235097
2022-07-28

Methods of treatment and related compositions

 #31
20220228167
2022-07-21

Peptide-Modified Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism and Increased Muscle Transduction

 #32
20220220157
2022-07-14

ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES

 #33
20220204566
2022-06-30

ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES

 #34
20220090123
2022-03-24

HIGH THROUGHPUT ASSAY FOR MEASURING ADENOVIRUS REPLICATION KINETICS

 #35
20220002352
2022-01-06

Influenza vaccines

 #36
20210380943
2021-12-09

GENERATING HPV ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION

 #37
20210324044
2021-10-21

Heterologous targeting peptide grafted AAVs

 #38
20210277355
2021-09-09

GENERATING VIRUS OR OTHER ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION

 #39
20210155660
2021-05-27

RATIONALLY DESIGNED VIRUS-LIKE PARTICLES FOR MODULATION OF CHIMERIC ANTIGEN RECEPTOR (CAR)-T-CELL THERAPY

 #40
20210130415
2021-05-06

CHEMICALLY-MODIFIED ADENO-ASSOCIATED VIRUS

 #41
20210122789
2021-04-29

AAV capsid polynucleotides and polypeptides and virions containing the same

 #42
20210115091
2021-04-22

Methods and compositions for dual glycan binding AAV vectors

 #43
20210113635
2021-04-22

Viral gene therapy as treatment for cholesterol storage disease or disorder

 #44
20210107948
2021-04-15

Hybrid recombinant adeno-associated virus serotype between AAV9 and AAVrh74 with reduced liver tropism

 #45
20200399323
2020-12-24

Recombinant adenoviruses and uses thereof

 #46
20200390906
2020-12-17

Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine

 #47
20200181208
2020-06-11

Adenovirus comprising an albumin-binding moiety

 #48
20200140886
2020-05-07

Adenovirus polynucleotides and polypeptides

 #49
20200140493
2020-05-07

Engineering Virus-like Nanocarriers for Biomolecule Delivery

 #50
20200131539
2020-04-30

CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous recombination of AAV donor vectors

 #51
20200123572
2020-04-23

Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus

 #52
20200121746
2020-04-23

ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSIDS AND METHODS OF USE THEREOF

 #53
20200024616
2020-01-23

Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism

 #54
20190389934
2019-12-26

Heterologous targeting peptide grafted AAVS

 #55
20190388487
2019-12-26

Detargeted adenovirus variants and related methods

 #56
20190367945
2019-12-05

Method of treating type I diabetes using an AAV vector encoding uracortin 2

 #57
20190276499
2019-09-12

Protein VII Fragments and Methods of Use Thereof for the Treatment of Inflammatory Disorders

 #58
20190134118
2019-05-09

Adeno-associated virus compositions for restoring HBB gene function and methods of use thereof

 #59
20180371024
2018-12-27

Methods and compositions for dual glycan binding AAV vectors

 #60
20180360993
2018-12-20

Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine

 #61
20180355374
2018-12-13

High throughput assay for measuring adenovirus replication kinetics

 #62
20180346876
2018-12-06

Chimeric antigen receptor cell preparation and uses thereof

 #63
20180311380
2018-11-01

Prostate-targeting adeno-associated virus serotype vectors

 #64
20180289742
2018-10-11

Method for preparing genetically-modified T cells which express chimeric antigen receptor

 #65
20180273907
2018-09-27

Method for producing non-enveloped viral particles

 #66
20180265571
2018-09-20

Heterologous targeting peptide grafted AAVS

 #67
20180258391
2018-09-13

Compositions and Methods for Treatment of Cancer

 #68
20180230187
2018-08-16

Influenza vaccines

 #69
20180170972
2018-06-21

Adenovirus polynucleotides and polypeptides

 #70
20180163229
2018-06-14

NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS CONTAINING A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN) OR FRAGMENT THEREOF

 #71
20180153946
2018-06-07

Oncolytic adenoviruses with mutations in immunodominant adenovirus epitopes and their use in cancer treatment

 #72
20180104289
2018-04-19

VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER

 #73
20180099015
2018-04-12

Detargeted adenovirus variants and related methods

 #74
20180072990
2018-03-15

GENERATING VIRUS OR OTHER ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION

 #75
20180010148
2018-01-11

Method of treating type I diabetes using an AAV vector encoding uracortin 2

 #76
20170283775
2017-10-05

Compositions and Methods for Treatment of Cancer

 #77
20170051022
2017-02-23

Adenovirus comprising an albumin-binding moiety

 #78
20170044217
2017-02-16

Prophylactic vaccine against egg drop syndrome (EDS)

 #79
20150306177
2015-10-29

Therapy for radiation-induced lung injury

 #80
20150037364
2015-02-05

Adenoviruses and their use

 #81
16512051
2020-05-19

Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency